Your (or your loved one’s) medical records contain clues that can lead to new treatments.
AllStripes researchers learn from patient records what would truly improve quality of life.
Using cutting-edge tech we analyze your community’s data to improve trial design and chances of success.
Your community’s de-identified records can advance multiple treatment studies.
We do the work to collect all your records, at no cost, in your secure account. Access doctors’ notes you’ve never seen.
See how your rare disease journey compares to others with your condition, and what’s helping.
We’ll send you exclusive updates on the studies you’re contributing to and how you’re driving forward research.
Inside each of our cells are mitochondria, or the powerhouses of the cell. Their job is to make the energy the body needs to function properly, including actions like lifting your arms or inflating your lungs with each breath. This energy is referred to as adenosine triphosphate, or ATP. To make ATP, mitochondria need enzymes, a type of protein. When there is an error, or mutation in the DNA that code for the enzyme or protein, the mutation can cause a mitochondrial disease. One type of mitochondrial disease is thymidine kinase 2 deficiency, or TK2d. TK2d is a very rare inherited genetic disease that results in an enzyme deficiency that affects mitochondrial DNA (mtDNA). With TK2d, less mtDNA is being made, which means muscles don’t have enough energy and cannot function right. Symptoms of TK2d include muscle weakness (myopathy), difficulty breathing, droopy or saggy eyelids, trouble chewing and swallowing or fatigue. TK2d can present in infants, children or adults.
1. Sign up
Create your private account and review our research consent (takes about 10 minutes)
2. We get to work
We do all the behind-the-scenes work to retrieve and process your records
3. Impact research
Power multiple research projects at once by contributing your de-identified data
We believe that the only way to keep data accessible to the researchers who need it is by enabling patients to own and control their own data. Patients decide for themselves whether they want to privately and securely contribute to research, rather than having the decision made on their behalf.
We aim to make useful data accessible to all researchers who have legitimate research questions or research programs. For academic research, we offer access without charge. We take research ethics seriously, and we have policies in place to ensure that research is conducted with integrity.
We don’t like to take sides—we give all members of the community the option to get involved. Success in rare disease research takes a village and we always welcome additional collaborators who can advance and benefit from the mission.
Our primary mission is to accelerate drug development, so we prioritize generating insights specifically relevant to therapeutic research. We invest deeply in quality, security, and compliance to make this a reality.